Publications by authors named "Rediet Mulatu"

Claim this Profile
C
Cilta-cel CAR T cells as an effective and well tolerated treatment for POEMS: a case study.
Matthew Williams, Djordje Atanackovic, Rediet Mulatu, Aerielle Matsangos, Daniel Yamoah

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphoma.
Nancy M Hardy, Jean A Yared, Tim Luetkens, Haroon Ahmad, Rediet Mulatu

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing trogocytosis by cathepsin B inhibition augments CAR T cell function.
Kenneth A Dietze, Kiet Nguyen, Aashli Pathni, Frank Fazekas, Wenxiang Sun, Rediet Mulatu

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma.
Djordje Atanackovic, Tim Luetkens, Dina Schneider, Peirong Hu, Xu Wang, Rediet Mulatu

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells.
Mehmet H Kocoglu, Tim Luetkens, Jacqueline T Bork, John Baddley, Destiny Omili, Rediet Mulatu

Blood Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis